Proteomic analysis of human prostate cancer †

Proteomics is a promising approach in the identification of proteins and biochemical pathways involved in tumorigenesis. In an effort to discover such proteins and pathways that are deregulated in prostate tumorigenesis, cellular proteomes of matched normal prostate epithelial cells and high‐grade prostate cancer cells were analyzed by tissue microdissection, two‐dimensional electrophoresis, and mass spectrometry. Forty protein alterations were detected in the tumors; however, the majority of these changes were not shared among the 12 neoplasms. In contrast, parallel cDNA microarray analysis identified a number of common gene expression changes. The marked heterogeneity of the observed protein alterations may have significance with regard to tumor biology and research strategies for molecular profiling analyses of human prostate cancer. Published 2002 Wiley‐Liss, Inc.

[1]  Carcinoma of the prostate. I. Histochemical examination as an aid in evaluating prostate carcinoma. , 1979, International urology and nephrology.

[2]  L. Penland,et al.  Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.

[3]  David Fenyö,et al.  Peer Reviewed: Internet-Based Analytical Chemistry Resources: A Model Project , 1996 .

[4]  P. Kantoff,et al.  Two differentially expressed genes in normal human prostate tissue and in carcinoma. , 1996, Cancer research.

[5]  S. Ménard,et al.  Independent prognostic value of the 67-kd laminin receptor in human prostate cancer. , 1997, Journal of the National Cancer Institute.

[6]  M Schena,et al.  Microarrays: biotechnology's discovery platform for functional genomics. , 1998, Trends in biotechnology.

[7]  N. Anderson,et al.  Proteome and proteomics: New technologies, new concepts, and new words , 1998, Electrophoresis.

[8]  Morten Østergaard,et al.  Human and mouse proteomic databases: novel resources in the protein universe , 1998, FEBS letters.

[9]  David B. Krizman,et al.  The genetics of cancer—a 3D model , 1999, Nature Genetics.

[10]  S. P. Fodor,et al.  High density synthetic oligonucleotide arrays , 1999, Nature Genetics.

[11]  D. Pappin,et al.  The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis — Preliminary findings , 1999, Electrophoresis.

[12]  E. Lander Array of hope , 1999, Nature Genetics.

[13]  E. Petricoin,et al.  An approach to proteomic analysis of human tumors , 2000, Molecular carcinogenesis.

[14]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[15]  E. Petricoin,et al.  Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines , 2000, Electrophoresis.

[16]  Twelfth International Conference on Carcinogenesis and Risk Assessment Gene Environment Interactions: Emerging issues, technologies, and biological paradigms , 2000 .

[17]  T Voss,et al.  Observations on the reproducibility and matching efficiency of two‐dimensional electrophoresis gels: Consequences for comprehensive data analysis , 2000, Electrophoresis.

[18]  G. Auer,et al.  Polypeptide Expression in Prostate Hyperplasia and Prostate Adenocarcinoma , 2000, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[19]  T. Ørntoft,et al.  Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics , 2000, FEBS letters.

[20]  P R Taylor,et al.  Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. , 2000, Cancer research.

[21]  J. Marks,et al.  A SAGE (serial analysis of gene expression) view of breast tumor progression. , 2001, Cancer research.

[22]  H. Jörnvall,et al.  Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry , 2001, Cellular and Molecular Life Sciences CMLS.

[23]  Ji Huang,et al.  [Serial analysis of gene expression]. , 2002, Yi chuan = Hereditas.